Efficacy and safety of tosufloxacin tosilate hydrate for the treatment of community-acquired pneumonia in childre
Not Applicable
- Conditions
- Community-acquired pneumonia
- Registration Number
- JPRN-UMIN000013321
- Lead Sponsor
- Society for the Use of Quinolones in Children
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who are not expected to recover by oral antimicrobial agents or those with urinary-tract infection. Patients who cannot take oral medications or those who refuse to take any drug. Patients who have a history of allergy to quinolone antibacterial agents. Patients who received antimicrobial agents before treatment with TFLX fine granules and whose conditions are improving. Patients who are suspected of having viral pneumonia or other diseases which are not expected to be resolved by TFLX fine granules. Other patients whom the physician deems to be ineligible for any reason.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical efficacy at the end of the treatment Bacteriological efficacy at the end of the treatment Adverse drug reactions
- Secondary Outcome Measures
Name Time Method